Back
PT Bank Central Asia Tbk Vs. Axsome Therapeutics Industry Stock Comparison
Sell
33
PBCRF
PT Bank Central Asia Tbk
Last Price:
$0.51
Seasonality Move:
-1.44%
Sell
35
AXSM
Axsome Therapeutics
Last Price:
$111.64
Seasonality Move:
19.74%
Sell
33
PT Bank Central Asia Tbk (PBCRF)
is a Sell
Is PT Bank Central Asia Tbk a Buy, Sell or Hold?
-
The current PT Bank Central Asia Tbk [PBCRF] share price is $0.51. The Score for PBCRF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
PBCRF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $111.67. The Score for AXSM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PBCRF Stock Price Chart
What is PT Bank Central Asia Tbk's stock price today?
-
The PT Bank Central Asia Tbk share price today is $0.51The current trend is relatively stagnant and PBCRF is experiencing buying pressure, which is a positive indicator for future bullish movement.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $111.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight buying pressure.
PBCRF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 48.33 | Sell |
Chaikin Money Flow: | 273004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.48 - 0.54) | Sell |
Bollinger Bands (100): | (0.53 - 0.63) | Sell |
AXSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 36.05 | Sell |
Chaikin Money Flow: | 647254 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119.19 - 127.47) | Sell |
Bollinger Bands (100): | (89.52 - 121.2) | Buy |
PBCRF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.49 | Buy |
20-day SMA: | 0.51 | Sell |
50-day SMA: | 0.54 | Sell |
200-day SMA: | 0.61 | Sell |
8-day EMA: | 0.5 | Buy |
20-day EMA: | 0.51 | Buy |
50-day EMA: | 0.53 | Sell |
200-day EMA: | 0.59 | Sell |
AXSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 120.51 | Sell |
20-day SMA: | 122.32 | Sell |
50-day SMA: | 118.5 | Sell |
200-day SMA: | 95.68 | Buy |
8-day EMA: | 118.83 | Sell |
20-day EMA: | 121.23 | Sell |
50-day EMA: | 116.96 | Sell |
200-day EMA: | 99.27 | Buy |
PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $1.82 per share, and an increase next year of $4.87 per share.
PT Bank Central Asia Tbk Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Axsome Therapeutics Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |